Abilene TX 地图样萎缩临床试验
3项针对 地图样萎缩的研究正在 Abilene及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
招募中1/2 期
- Retina Research Institute of Texas, Abilene
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
招募中3 期
- Retina Research Institute of Texas, Abilene
Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
招募中1/2 期
- Retina Research Institute of Texas /ID# 262141, Abilene
其他城市的 地图样萎缩试验
- Dallas, TX8 项研究
- Reno, NV8 项研究
- Austin, TX7 项研究
- Santa Monica, CA7 项研究
- Naperville, IL6 项研究
- The Woodlands, TX6 项研究
- Baltimore, MD6 项研究
- Cleveland, OH6 项研究
- Houston, TX6 项研究
- San Antonio, TX5 项研究
- Hagerstown, MD5 项研究
- Spokane, WA5 项研究
Abilene的其他研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月1日。每项研究自行设定入选标准，由研究团队决定谁能参与。